Yuan Chang
Physician at 168 St, New York, NY
License number
Colorado 31516
Issued Date
Feb 14, 1992
Renew Date
May 31, 1993
Expiration Date
May 31, 1993
Type
Physician
Address
Address
630 W 168Th St, New York, NY 10032
Organization information
See more information about Yuan Chang at bizstanding.comLIN YUAN CHANG SESAME OIL FOOD CO., LTD. (U.S.A.)
173 Chrystie St, New York, NY 10002
Status:
Inactive
Inactive reason:
Dissolution by Proclamation / Annulment of Authority
Registration:
Sep 15, 1986
Inactive since:
Jun 24, 1992
State ID:
1112020
Business type:
DOMESTIC BUSINESS CORPORATION
Professional information
Unique Associated Kaposi's Sarcoma Virus Sequences And Uses Thereof
US Patent:
6093550, Jul 25, 2000
Filed:
Oct 30, 1998
Appl. No.:
9/183688
Inventors:
Yuan Chang - New York NY
Patrick S. Moore - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
G01N 3353, C12N 500, A61K 39245, C07H 2104
US Classification:
435 71
Abstract:
This invention provides an isolated DNA molecule which is at least 30 nucleotides in length and which uniquely defines a herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated peptide encoded by the isolated DNA molecule. Further, this invention provides an isolated DNA virus wherein the viral DNA is about 270 kb in size; wherein the DNA encodes a thymidine kinase; and wherein the viral DNA is capable of selectively hybridizing to a nucleic acid probe selected from the group consisting of SEQ. ID NOs: 10-12. This invention provides an antibody specific to the peptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a transgenic nonhuman mammal and a cell line containing at least a portion of the isolated DNA molecule. This invention provides a method of vaccinating a subject for KS, prophylaxis diagnosing or treating a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
Kaposi's Sarcoma-Associated Herpesvirus (Kshv) Interleukin 6 (Il-6) And Uses Thereof
US Patent:
5861500, Jan 19, 1999
Filed:
Jul 25, 1996
Appl. No.:
8/686349
Inventors:
Yuan Chang - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 39245, C07H 2104, C07K 1403, C12N 1538
US Classification:
536 2372
Abstract:
This invention provides an isolated DNA molecule which encodes interleukin 6 (IL-6) of Kaposi's sarcoma-associated herpesvirus. Antisense oligonucleotide molecules are also provided.
Unique Associated Kaposi's Sarcoma Virus Sequences And Uses Thereof
US Patent:
5801042, Sep 1, 1998
Filed:
Apr 11, 1995
Appl. No.:
8/420235
Inventors:
Yuan Chang - New York NY
Patrick S. Moore - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C12N 121, C12N 510, C12N 1538, C12N 1563
US Classification:
4352523
Abstract:
This invention provides an isolated DNA molecule which is at least 30 nucleotides in length and which uniquely defines a herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated herpesvirus associated with Kaposi's sarcoma. This invention provides an antibody specific to the peptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a method of vaccinating a subject for KS, prophylaxis, diagnosing or treating a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
Virion Protein 26 From Kaposi's Sarcoma-Associated Herpesvirus, Dna Encoding Same And Uses Thereof
US Patent:
5859225, Jan 12, 1999
Filed:
Sep 5, 1996
Appl. No.:
8/708678
Inventors:
Yuan Chang - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07H 2104, A61K 39245, C12Q 168, C12N 700
US Classification:
536 2372
Abstract:
This invention provides an isolated nucleic acid molecule which encodes KSHV virion protein 26. This invention provides an isolated polypeptide molecule which encodes KSHV virion protein 26. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine and method of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
Unique Associated Kaposi's Sarcoma Virus Sequences And Uses Thereof
US Patent:
2011026, Oct 27, 2011
Filed:
Apr 26, 2011
Appl. No.:
13/094522
Inventors:
Yuan Chang - New York NY, US
Patrick S. Moore - New York NY, US
Patrick S. Moore - New York NY, US
International Classification:
A01K 67/033, A61K 39/42, A61P 31/22, C07K 16/08, C07K 14/03, A61P 37/04, C07H 21/04, C12N 9/38
US Classification:
800 13, 536 245, 536 231, 4241591, 530395, 435207, 5303894, 5303883, 530350
Abstract:
This invention provides an isolated peptide encoded by a nucleic acid which is at least 30 nucleotides in length and has a sequence which uniquely defines a herpesvirus associated with Kaposis' sarcoma, which herpesvirus is present in and recoverable from the HBL-6 cell line (ATCC Accession No. CRL 11762).
Polypeptides From Kaposi's Sarcoma-Associated Herpesvirus, Dna Encoding Same And Uses Thereof
US Patent:
5849564, Dec 15, 1998
Filed:
Nov 29, 1996
Appl. No.:
8/770379
Inventors:
Yuan Chang - New York NY
Roy A. Bohenzky - Mountian View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Roy A. Bohenzky - Mountian View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07H 2104, C12N 1563, C12N 120
US Classification:
4352523
Abstract:
This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) polypeptides. This invention provides an isolated polypeptide molecule of KSHV. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposi's Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
Unique Associated Kaposi's Sarcoma Virus Sequences And Uses Thereof
US Patent:
6150093, Nov 21, 2000
Filed:
Feb 18, 1997
Appl. No.:
8/793624
Inventors:
Yuan Chang - New York NY
Patrick S. Moore - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C12Q 168, C12N 510, C12N 700, C12N 1563
US Classification:
435 6
Abstract:
This invention provides an isolated DNA molecule which is at least 30 nucleotides in length and which uniquely defines a herpesvirus associated with Kaposi's sarcoma. This invention provides an isolated herpesvirus associated with Kaposi's sarcoma. This invention provides an antibody specific to the peptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a method of vaccinating a subject for KS, prophylaxis diagnosing or treating a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
Unique Associated Kaposi's Sarcoma Virus Sequences And Uses Thereof
US Patent:
7932066, Apr 26, 2011
Filed:
May 9, 2007
Appl. No.:
11/801641
Inventors:
Yuan Chang - New York NY, US
Patrick S. Moore - New York NY, US
Patrick S. Moore - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C12N 9/00, C07K 5/00
US Classification:
435174, 530300
Abstract:
This invention provides an isolated peptide encoded by a nucleic acid which is at least 30 nucleotides in length and has a sequence which uniquely defines a herpesvirus associated with Kaposis' sarcoma, which herpesvirus is present in and recoverable from the HBL-6 cell line (ATCC Accession No. CRL 11762).
Kaposi's Sarcoma-Associated Herpesvirus (Kshv) Interleukin 6 (Il-6) And Uses Thereof
US Patent:
5854398, Dec 29, 1998
Filed:
Nov 13, 1996
Appl. No.:
8/748640
Inventors:
Yuan Chang - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07K 1608, A61K 39245, G01N 3350, C07H 2104
US Classification:
5303871
Abstract:
This invention provides an antibody specific to the peptide of KSHVIL-6.
Kaposi's Sarcoma-Associated Herpesvirus (Kshv) Glycoprotein B (Gb) And Uses Thereof
US Patent:
5863787, Jan 26, 1999
Filed:
Jul 25, 1996
Appl. No.:
8/686243
Inventors:
Yuan Chang - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07H 2104, C12N 121, C12N 1538, C12P 1934
US Classification:
4352523
Abstract:
This invention provides an isolated DNA molecule which encodes glycoprotein B (gB). Antisense and triplex oligonucleotide molecules are also provided.